" />

Login

Login

Generate password

Change password

Forgot Customer Code

Would you like to create a personalised login id for logging in to Emkay Website ?

Change Personalised Login ID

Eiko Lifesciences - Board Meeting Outcome for Outcome Of Board Meetinng

Share Source By

Dion Global

12 Feb 2025

Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), and amendments thereto, this is to inform that the Meeting of the Board of Directors of the Company held today i.e., on Wednesday, 12th February, 2025, Board, inter-alia, considered and approved the Unaudited Financial Results (Standalone & Consolidation basis) for the quarter and nine months ended 31st December, 2024. \r\n\r\nThe Statutory Auditor has carried out a 'Limited Review' of the Unaudited Financial Results for the quarter and nine months ended 31st December, 2024. Further, Pursuant to the Regulation 33 of the Listing Regulations, we are enclosing herewith a copy of the Unaudited Financial Results and Limited Review Report of the Statutory Auditors of the Company.\r\n\r\n\r\n The Meeting was commenced at 5:30 P.M. and concluded at 8:35 P.M.\r\n\r\n